Last edition
News about "Naga Chalasani"
Zydus Reports Positive Phase 2b Results for Saroglitazar in MASH
Zydus reports positive phase 2b EVIDENCES-X results for saroglitazar magnesium in MASH, meeting its primary endpoint of steatohepatitis resolution without worsening fibrosis.
Naga Chalasani | 31/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members